Annual Total Long Term Liabilities
$13.44 M
+$628.00 K+4.90%
December 31, 2023
Summary
- As of February 8, 2025, KROS annual total long term liabilities is $13.44 million, with the most recent change of +$628.00 thousand (+4.90%) on December 31, 2023.
- During the last 3 years, KROS annual total long term liabilities has risen by +$12.90 million (+2397.96%).
- KROS annual total long term liabilities is now at all-time high.
Performance
KROS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$17.43 M
+$4.57 M+35.52%
September 30, 2024
Summary
- As of February 8, 2025, KROS quarterly total long term liabilities is $17.43 million, with the most recent change of +$4.57 million (+35.52%) on September 30, 2024.
- Over the past year, KROS quarterly long term liabilities has increased by +$3.99 million (+29.69%).
- KROS quarterly long term liabilities is now at all-time high.
Performance
KROS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
KROS Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.9% | +29.7% |
| 3 y3 years | +2398.0% | +3616.2% |
| 5 y5 years | +321.9% | - |
KROS Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +5717.8% | at high | -100.0% |
| 5 y | 5-year | at high | +5717.8% | at high | -100.0% |
| alltime | all time | at high | +5717.8% | at high | -100.0% |
Keros Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.43 M(+35.5%) |
| Jun 2024 | - | $12.86 M(-2.2%) |
| Mar 2024 | - | $13.15 M(-2.1%) |
| Dec 2023 | $13.44 M(+4.9%) | $13.44 M(-1.9%) |
| Sep 2023 | - | $13.70 M(-1.8%) |
| Jun 2023 | - | $13.95 M(-0.3%) |
| Mar 2023 | - | $13.99 M(+9.2%) |
| Dec 2022 | $12.81 M | $12.81 M(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $0.00(-100.0%) |
| Dec 2021 | $231.00 K(-57.1%) | $231.00 K(-50.7%) |
| Sep 2021 | - | $469.00 K(+71.2%) |
| Jun 2021 | - | $274.00 K(-32.8%) |
| Mar 2021 | - | $408.00 K(-24.2%) |
| Dec 2020 | $538.00 K(-91.0%) | $538.00 K(-18.9%) |
| Sep 2020 | - | $663.00 K(-15.3%) |
| Jun 2020 | - | $783.00 K(-13.1%) |
| Mar 2020 | - | $901.00 K(-84.9%) |
| Dec 2019 | $5.97 M(+87.6%) | $5.97 M |
| Dec 2018 | $3.19 M | - |
FAQ
- What is Keros Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Keros Therapeutics?
- What is Keros Therapeutics annual total long term liabilities year-on-year change?
- What is Keros Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Keros Therapeutics?
- What is Keros Therapeutics quarterly long term liabilities year-on-year change?
What is Keros Therapeutics annual total long term liabilities?
The current annual total long term liabilities of KROS is $13.44 M
What is the all time high annual total long term liabilities for Keros Therapeutics?
Keros Therapeutics all-time high annual total long term liabilities is $13.44 M
What is Keros Therapeutics annual total long term liabilities year-on-year change?
Over the past year, KROS annual total long term liabilities has changed by +$628.00 K (+4.90%)
What is Keros Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of KROS is $17.43 M
What is the all time high quarterly long term liabilities for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total long term liabilities is $17.43 M
What is Keros Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, KROS quarterly total long term liabilities has changed by +$3.99 M (+29.69%)